02.16.16
The Pharma & Biopharma Outsourcing Association (PBOA), the trade association for CMOs and CDMOs, recently added several new member companies, as well as a new member on its board of trustees.
IDT Biologika and Ei SolutionWorks joined the PBOA as general members, while 3M Drug Delivery Systems joined as a sustaining member of the association. Diego Romeu, manufacturing and supply chain director at 3M DDS, was also voted to the board of trustees, along with Rajan Puri, director of business development at Therapure, and Lee Karras, chief executive officer, Halo Pharmaceutical.
“As we continue our mission to represent the CMO/CDMO industry before FDA, Congress and other stakeholders, it’s critical that we increase our membership and provide a true voice for our industry,” said Gil Roth, president of the PBOA. “We’ve been successful in bringing the CMO/CDMO perspective to issues such as GDUFA, quality metrics, and serialization, and we’re delighted to bring in new member companies and add fresh points of view to our board of trustees.”
“At 3M, we always want to be ahead of the issues our customers will face so that we’re providing the highest quality partnership possible,” said Diego Romeu, manufacturing and supply chain director, 3M Drug Delivery Systems. “Joining the Pharma & Biopharma Outsourcing Association, which shares many of our goals related to quality CMO/CDMO partnerships, is very exciting for us and for the future of pharma.”
“Ei is excited to join our colleagues in the pharma outsourcing industry and contribute to the PBOA,” said Roger Martin, president pharma division, Ei LLC. “The team at Ei feels the issues PBOA is involved with, including GDUFA, general FDA regulation, and the evolving marketplace legislation, is paramount to our growth as an industry.”
Ralf Pfirmann, chief executive officer, IDT Biologika, said, “In the global arena of CMOs it is important to have an association speaking for companies and institutions, taking care of the important topics in the different areas of this business, arguing with one voice towards the authorities. A unified view of the CMO companies will be helpful in responding to future regulatory demands.”
Mr. Romeu, Mr. Karras and Mr. Puri will each serve three-year terms on the PBOA’s board.
IDT Biologika and Ei SolutionWorks joined the PBOA as general members, while 3M Drug Delivery Systems joined as a sustaining member of the association. Diego Romeu, manufacturing and supply chain director at 3M DDS, was also voted to the board of trustees, along with Rajan Puri, director of business development at Therapure, and Lee Karras, chief executive officer, Halo Pharmaceutical.
“As we continue our mission to represent the CMO/CDMO industry before FDA, Congress and other stakeholders, it’s critical that we increase our membership and provide a true voice for our industry,” said Gil Roth, president of the PBOA. “We’ve been successful in bringing the CMO/CDMO perspective to issues such as GDUFA, quality metrics, and serialization, and we’re delighted to bring in new member companies and add fresh points of view to our board of trustees.”
“At 3M, we always want to be ahead of the issues our customers will face so that we’re providing the highest quality partnership possible,” said Diego Romeu, manufacturing and supply chain director, 3M Drug Delivery Systems. “Joining the Pharma & Biopharma Outsourcing Association, which shares many of our goals related to quality CMO/CDMO partnerships, is very exciting for us and for the future of pharma.”
“Ei is excited to join our colleagues in the pharma outsourcing industry and contribute to the PBOA,” said Roger Martin, president pharma division, Ei LLC. “The team at Ei feels the issues PBOA is involved with, including GDUFA, general FDA regulation, and the evolving marketplace legislation, is paramount to our growth as an industry.”
Ralf Pfirmann, chief executive officer, IDT Biologika, said, “In the global arena of CMOs it is important to have an association speaking for companies and institutions, taking care of the important topics in the different areas of this business, arguing with one voice towards the authorities. A unified view of the CMO companies will be helpful in responding to future regulatory demands.”
Mr. Romeu, Mr. Karras and Mr. Puri will each serve three-year terms on the PBOA’s board.
